ES2120713T3 - Compuestos de isoxazolinas utiles como antagonistas de receptores del fibrinogeno. - Google Patents
Compuestos de isoxazolinas utiles como antagonistas de receptores del fibrinogeno.Info
- Publication number
- ES2120713T3 ES2120713T3 ES95901913T ES95901913T ES2120713T3 ES 2120713 T3 ES2120713 T3 ES 2120713T3 ES 95901913 T ES95901913 T ES 95901913T ES 95901913 T ES95901913 T ES 95901913T ES 2120713 T3 ES2120713 T3 ES 2120713T3
- Authority
- ES
- Spain
- Prior art keywords
- fibrinogen receptor
- receptor antagonists
- compounds useful
- compounds
- isoxazoline compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
ESTA INVENCION SE REFIERE A LAS NUEVAS ISOXAZOLINAS, UTILES COMO ANTAGONISTAS DEL COMPLEJO RECEPTOR DEL FIBRINOGENO TROMBOCITARIO GLICOPROTEICO IIB/IIIA, A LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS, PROCESOS PARA PREPARARLOS Y A LOS METODOS PARA UTILIZARLOS, POR SEPARADO O EN COMBINACION CON OTROS AGENTES TERAPEUTICOS, PARA LA INHIBICION DEL CONJUNTO DE TROMBOCITOS, COMO TROMBOLITICOS Y/O PARA EL TRATAMIENTO DE TRASTORNOS TROMBOEMBOLICOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15785193A | 1993-11-24 | 1993-11-24 | |
US08/304,614 US5446056A (en) | 1993-11-24 | 1994-09-12 | Isoxazoline compounds useful as fibrinogen receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2120713T3 true ES2120713T3 (es) | 1998-11-01 |
Family
ID=26854532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95901913T Expired - Lifetime ES2120713T3 (es) | 1993-11-24 | 1994-11-14 | Compuestos de isoxazolinas utiles como antagonistas de receptores del fibrinogeno. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0730589B1 (es) |
JP (1) | JPH09505589A (es) |
AT (1) | ATE168106T1 (es) |
AU (1) | AU677481B2 (es) |
CA (1) | CA2174415A1 (es) |
DE (1) | DE69411584T2 (es) |
DK (1) | DK0730589T3 (es) |
ES (1) | ES2120713T3 (es) |
NZ (1) | NZ276631A (es) |
WO (1) | WO1995014682A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
IL118007A0 (en) * | 1995-05-24 | 1996-08-04 | Du Pont Merck Pharma | Isoxazoline compounds pharmaceutical compositions containing them and their use |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
US5939418A (en) * | 1995-12-21 | 1999-08-17 | The Dupont Merck Pharmaceutical Company | Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors |
JP2001502655A (ja) * | 1995-12-21 | 2001-02-27 | デュポン ファーマシューティカルズ カンパニー | Xa因子阻害薬であるイソオキサゾリン、イソチアゾリンおよびピラゾリン |
EP0888344A1 (en) * | 1996-03-15 | 1999-01-07 | The Du Pont Merck Pharmaceutical Company | Spirocycle integrin inhibitors |
ZA972195B (en) * | 1996-03-15 | 1998-09-14 | Du Pont Merck Pharma | Spirocycle integrin inhibitors |
EP0922039A1 (en) * | 1996-08-15 | 1999-06-16 | Du Pont Pharmaceuticals Company | Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
JP2002511052A (ja) * | 1996-08-29 | 2002-04-09 | メルク エンド カンパニー インコーポレーテッド | インテグリンアンタゴニスト |
AU6780398A (en) * | 1997-03-28 | 1998-10-22 | Du Pont Merck Pharmaceutical Company, The | Heterocyclic integrin inhibitor prodrugs |
US7109326B2 (en) | 1997-04-15 | 2006-09-19 | Genentech, Inc. | Halo-alkoxycarbonyl prodrugs |
ES2239806T3 (es) | 1997-06-19 | 2005-10-01 | Bristol-Myers Squibb Pharma Company | Inhibidores del factor xa con un grupo de especificidad neutro p1. |
US5998424A (en) | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
ZA988735B (en) | 1997-10-06 | 2000-03-23 | Du Pont Pharm Co | An efficient method for the conversion of nitriles to amidines. |
CA2321538A1 (en) * | 1998-03-27 | 1999-10-07 | Dupont Pharmaceuticals Company | Disubstituted pyrazolines and triazolines as factor xa inhibitors |
WO2000000481A1 (en) * | 1998-06-29 | 2000-01-06 | Du Pont Pharmaceuticals Company | Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
US6319937B1 (en) | 1998-11-18 | 2001-11-20 | Dupont Pharmaceuticals Company | Isoxazoline fibrinogen receptor antagonists |
CA2345210A1 (en) | 1998-11-18 | 2000-05-25 | Prabhakar Kondaji Judhav | Novel isoxazoline fibrinogen receptor antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US5239113A (en) * | 1991-10-15 | 1993-08-24 | Monsanto Company | Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof |
-
1994
- 1994-11-14 ES ES95901913T patent/ES2120713T3/es not_active Expired - Lifetime
- 1994-11-14 WO PCT/US1994/013153 patent/WO1995014682A1/en active IP Right Grant
- 1994-11-14 AU AU10978/95A patent/AU677481B2/en not_active Ceased
- 1994-11-14 DE DE69411584T patent/DE69411584T2/de not_active Expired - Fee Related
- 1994-11-14 NZ NZ276631A patent/NZ276631A/en unknown
- 1994-11-14 JP JP7515116A patent/JPH09505589A/ja not_active Ceased
- 1994-11-14 CA CA002174415A patent/CA2174415A1/en not_active Abandoned
- 1994-11-14 DK DK95901913T patent/DK0730589T3/da active
- 1994-11-14 AT AT95901913T patent/ATE168106T1/de not_active IP Right Cessation
- 1994-11-14 EP EP95901913A patent/EP0730589B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH09505589A (ja) | 1997-06-03 |
AU1097895A (en) | 1995-06-13 |
NZ276631A (en) | 1997-06-24 |
AU677481B2 (en) | 1997-04-24 |
DE69411584D1 (de) | 1998-08-13 |
EP0730589B1 (en) | 1998-07-08 |
DK0730589T3 (da) | 1999-02-01 |
WO1995014682A1 (en) | 1995-06-01 |
EP0730589A1 (en) | 1996-09-11 |
DE69411584T2 (de) | 1998-12-17 |
CA2174415A1 (en) | 1995-06-01 |
ATE168106T1 (de) | 1998-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL118262A0 (en) | Isoxazolines and pharmaceutical compositions containing them | |
IL111721A (en) | Isoxazolines and isoxazoles and pharmaceutical compositions containing them | |
ES2120713T3 (es) | Compuestos de isoxazolinas utiles como antagonistas de receptores del fibrinogeno. | |
ES2131533T3 (es) | Compuestos ciclicos utiles como inhibidores del complejo glicoproteico plaquetario iib/iiia. | |
FI960727A0 (fi) | Neurokiniiniantagonisteina käyttökelpoiset heterosyklit | |
ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
WO2005035495A3 (en) | Fibrinogen receptor antagonists and their use | |
WO2000029406A3 (en) | Novel isoxazoline fibrinogen receptor antagonists | |
DE69429856D1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
MX9709081A (es) | Nuevos antagonistas del receptor fibrinogeno de isoxazolina e isoxazol. | |
BR0107179A (pt) | Amidinas cìclicas e acìclicas e composições farmacêuticas contendo as mesmas para uso como agentes de ligação de receptor de progesterona | |
GB189622666A (en) | Improvements in the Treatment of Ground Slags Intended for Use as Fertilisers. | |
FR80949E (fr) | Appareil pour l'enfoncement de tiges de fixation, notamment de clous, aiguilles ou pièces analogues, dans des matériaux durs, tels que pierre, béton, fer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 730589 Country of ref document: ES |